On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


ChineseInvestors.com, Inc. (CIIX) Leverages MJ Biz Con Event for Visibility and Investor Traction

  • CIIX announces an official media partnership with Marijuana Business Daily for its flagship event, MJ Biz Con
  • ChineseInvestors.com, Inc. leveraging MJ Biz Con visibility to enhance investor community traction
  • CIIX CEO sees a positive growth outlook for 2019 in the industrial hemp cannabidiol product line

ChineseInvestors.com, Inc. (OTCQB: CIIX) has grown to be a leading financial information website targeting Chinese investors in the U.S. and elsewhere. Founded in 1999, the company focuses on providing real-time market analysis, commentary and education-related services. In addition, CIIX offers consultative services aimed at small private companies, advertising services and public relations support products.

The company recently announced an official media partnership with Denver-based business news outlet Marijuana Business Daily. This has seen CIIX feature prominently at the ongoing Marijuana Business Daily flagship event (http://ibn.fm/IbTGV) underway at the Las Vegas Convention Center through November 16.

According to Warren Wang, CEO of CIIX, the company has positioned itself to play a strong leadership role at MJ Biz Con. The conference is strategic for the company because of the visibility it provides. CIIX plans to leverage the opportunity that the conference presents to develop alliances and identify new revenue opportunities.

During the conference, CIIX aimed to receive additional visibility at a networking lunch and presentation held on November 15 at Las Vegas’ Capital Grille. In attendance were Alan Stone & Company, Southern California Investment Forum and Wallstreet Research.

ChineseInvestors.com, Inc. was also present during the National Investment Banking Association Conference (http://ibn.fm/f8YKV) that was held in New York from October 31 to November 1, 2018. This conference gave investors a better understanding and favorable perspective of the industry growth prospects of CIIX.  The company, led by Wang, aims at sharing its investment story with the audience at MJ Biz Con in a bid to gain further traction and investor confidence.

Leveraging its financial expertise, CIIX, through subsidiary CBD Biotechnology Co. Ltd., recently entered into a key distribution agreement for industrial hemp cannabidiol. With the evolving regulatory and political landscape, the Chinese market for industrial hemp cannabidiol is likely to drive revenue growth for the company.

In its first fiscal quarter of 2019, ChineseInvestors.com, Inc. announced revenue growth of 70 percent year-on-year, with product sales up more than eight times. In fiscal year 2019, the company has planned to inject more marketing resources into the industrial hemp cannabidiol product line. This move is likely to enhance its growth numbers.

The main operating revenue sources for the company are investor relation service, subscriptions and sales of products. Just like most companies in this industry, the lion’s share of operating expenses is taken up by general and administrative costs. They accounted for 86 percent of the company’s total operating expenses for the quarterly period ended August 31, 2018.

For more information, visit the company’s website at www.ChineseInvestors.com

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.